HL7 Europe Patient Summary
1.0.0-ballot - ci-build
150
HL7 Europe Patient Summary
1.0.0-ballot - ci-build
150
This page is part of the HL7 Europe European Patient Summary (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
{
"resourceType" : "Composition",
"id" : "24c0f4df-ed5c-4a81-b34f-6d7cfffe310b",
"meta" : {
"profile" : [
🔗 "http://hl7.eu/fhir/eps/StructureDefinition/composition-eu-eps"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Composition 24c0f4df-ed5c-4a81-b34f-6d7cfffe310b</b></p><a name=\"24c0f4df-ed5c-4a81-b34f-6d7cfffe310b\"> </a><a name=\"hc24c0f4df-ed5c-4a81-b34f-6d7cfffe310b\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-composition-eu-eps.html\">Composition (EPS)</a></p></div><p><b>identifier</b>: <code>urn:ietf:rfc:9562</code>/4efe560e-aeef-4419-9a57-4b6af5c05779</p><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:{http://loinc.org 60591-5}\">Patient summary Document</span></p><p><b>date</b>: 2025-08-31 17:46:55+0000</p><p><b>author</b>: <a href=\"PractitionerRole-01d682e6-bb2d-4b31-9d3c-51cdc6dfb39b.html\">PractitionerRole</a></p><p><b>title</b>: European Patient Summary</p><p><b>confidentiality</b>: normal</p><p><b>custodian</b>: <a href=\"Organization-ce815734-508a-4c1d-8b63-01e1d02a5614.html\">Organization BfA-Klinik</a></p></div>"
},
"identifier" : {
"system" : "urn:ietf:rfc:9562",
"value" : "4efe560e-aeef-4419-9a57-4b6af5c05779",
"assigner" : {
"display" : "HL7 Europe"
}
},
"status" : "final",
"type" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "60591-5",
"display" : "Patient summary Document"
}
],
"text" : "Patient summary Document"
},
"subject" : {
🔗 "reference" : "Patient/f0b2dcfe-e837-464b-ae8a-3b9da1807dd3"
},
"date" : "2025-08-31T17:46:55Z",
"author" : [
{
🔗 "reference" : "PractitionerRole/01d682e6-bb2d-4b31-9d3c-51cdc6dfb39b"
}
],
"title" : "European Patient Summary",
"confidentiality" : "N",
"custodian" : {
🔗 "reference" : "Organization/ce815734-508a-4c1d-8b63-01e1d02a5614"
},
"section" : [
{
"title" : "Problem list",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "11450-4",
"display" : "Problem list - Reported"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><th>Condition</th><th>Onset Date</th><th>Status</th></tr><tr><td>Hyperlipidemia</td><td><span class=\"nb\">2020-06-15</span></td><td>active</td></tr><tr><td>Emphysematous bronchitis</td><td><span class=\"nb\">2020-06-15</span></td><td>active</td></tr><tr><td>Ischemic heart disease</td><td><span class=\"nb\">2010-04-19</span></td><td>active</td></tr><tr><td>Chronic sinusitis</td><td><span class=\"nb\">1994-01-16</span></td><td>active</td></tr><tr><td>Anemia</td><td><span class=\"nb\">1993-02-22</span></td><td>active</td></tr><tr><td>Prediabetes</td><td><span class=\"nb\">1991-02-18</span></td><td>active</td></tr></table></div>"
},
"entry" : [
{
🔗 "reference" : "Condition/1945356e-a6aa-498e-9aee-9f708bd78c35"
}
]
},
{
"title" : "Medication list",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "10160-0",
"display" : "History of Medication use Narrative"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><th>Medication</th><th>Since</th><th>Form</th><th>Dosage</th><th>Reason</th></tr><tr><td>Simvastatin 10 mg oral tablet</td><td><span class=\"nb\">2025-07-15</span></td><td>Oral tablet</td><td>1 tablet (10 mg) by mouth once daily</td><td>Hyperlipidemia</td></tr><tr><td>Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation</td><td><span class=\"nb\">2025-07-14</span></td><td>Solution for inhalation</td><td>2.5 mg (0.5 mL of 5 mg/mL solution) via nebulizer every 4 to 6 hours as needed</td><td>Chronic obstructive bronchitis (disorder)</td></tr><tr><td>Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet</td><td><span class=\"nb\">2025-07-14</span></td><td>Oral tablet</td><td>1 tablet (300 mg/5 mg) by mouth every 4 to 6 hours as needed for pain</td><td/></tr><tr><td>60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler</td><td><span class=\"nb\">2025-07-14</span></td><td/><td>1 inhalation (0.25 mg/0.05 mg) twice daily</td><td>Chronic obstructive bronchitis (disorder)</td></tr><tr><td>Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet</td><td><span class=\"nb\">2010-04-26</span></td><td>Oral tablet</td><td>1 tablet (75 mg) by mouth once daily</td><td/></tr><tr><td>Simvastatin 20 mg oral tablet</td><td><span class=\"nb\">2010-04-26</span></td><td>Oral tablet</td><td>1 tablet (20 mg) by mouth once daily</td><td/></tr><tr><td>Nitroglycerin 400 microgram/actuation sublingual spray</td><td><span class=\"nb\">2010-04-26</span></td><td>Sublingual spray</td><td>400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes</td><td/></tr><tr><td>Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet</td><td><span class=\"nb\">2010-04-26</span></td><td>Prolonged-release oral tablet</td><td>1 tablet (100 mg) once daily</td><td/></tr><tr><td>doxycycline hyclate 100 MG</td><td><span class=\"nb\">2008-08-12</span></td><td/><td>100 mg twice daily</td><td>Viral sinusitis (disorder)</td></tr><tr><td>Astemizole 10 mg oral tablet</td><td><span class=\"nb\">1978-10-26</span></td><td>Oral tablet</td><td>1 tablet (10 mg) once daily</td><td/></tr><tr><td>Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream</td><td><span class=\"nb\">1978-10-11</span></td><td>Cutaneous cream</td><td>Apply a thin layer (approximately 1 g) to the affected area twice daily</td><td>Contact dermatitis</td></tr></table></div>"
},
"entry" : [
{
🔗 "reference" : "MedicationStatement/b3a1ed32-3f44-41e2-919b-1c8bdeaee29c"
}
]
},
{
"title" : "Immunizations list",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "11369-6",
"display" : "History of Immunization note"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><th>Vaccine</th><th>Date</th></tr><tr><td>Influenza virus antigen only vaccine product</td><td><span class=\"nb\">2025-07-14</span></td></tr><tr><td>SARS-CoV-2 mRNA vaccine</td><td><span class=\"nb\">2021-03-01</span></td></tr><tr><td>Clostridium tetani toxoid antigen adsorbed only vaccine product</td><td><span class=\"nb\">2018-06-04</span></td></tr></table></div>"
},
"entry" : [
{
🔗 "reference" : "Immunization/2c268a6d-fd6e-4580-acae-3b5f52d43c26"
}
]
},
{
"title" : "Allergies and Intolerances",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "48765-2",
"display" : "Allergies and adverse reactions Document"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><th>Allergy/Intolerance</th><th>Onset Date</th><th>Status</th><th>Type</th><th>Reaction</th></tr><tr><td>Penicillin V</td><td><span class=\"nb\">1978-10-26</span></td><td>active</td><td>medication</td><td/></tr><tr><td>Allergy to substance</td><td><span class=\"nb\">1978-10-26</span></td><td>active</td><td>environment</td><td/></tr></table></div>"
},
"entry" : [
{
🔗 "reference" : "AllergyIntolerance/d5cab1c1-382d-418c-a1b6-1c21408fcfe5"
}
]
},
{
"title" : "Care Plan",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "18776-5",
"display" : "Plan of care note"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><th>Immunization Recommendation</th><th>Due Date</th><th>Reason</th></tr><tr><td>Vaccine product containing only Influenza virus antigen (medicinal product)</td><td><span class=\"nb\">2025-10-01</span></td><td>Annual seasonal influenza vaccination</td></tr></table></div>"
},
"entry" : [
{
🔗 "reference" : "CarePlan/81b033d8-ab2e-4eee-8792-3b9c6261869d"
}
]
},
{
"title" : "History of Procedures",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "47519-4",
"display" : "History of Procedures Document"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><td>No known procedures</td></tr></table></div>"
},
"emptyReason" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/list-empty-reason",
"code" : "nilknown"
}
]
}
},
{
"title" : "Vital Signs",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "8716-3",
"display" : "Vital signs note"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><th>Vital Signs</th><th>2025-07-14</th><th>2024-07-08</th></tr><tr><td>Body Height</td><td>158.3 cm</td><td>158.3 cm</td></tr><tr><td>Pain severity - 0-10 verbal numeric rating [Score] - Reported</td><td>3 {score}</td><td>2 {score}</td></tr><tr><td>Body Weight</td><td>73.3 kg</td><td>71.3 kg</td></tr><tr><td>Body mass index (BMI) [Ratio]</td><td>29.2 kg/m2</td><td>28.5 kg/m2</td></tr><tr><td>Diastolic Blood Pressure</td><td>55 mm[Hg]</td><td>62 mm[Hg]</td></tr><tr><td>Systolic Blood Pressure</td><td>113 mm[Hg]</td><td>104 mm[Hg]</td></tr><tr><td>Heart rate</td><td>80 /min</td><td>72 /min</td></tr><tr><td>Respiratory rate</td><td>13 /min</td><td>14 /min</td></tr></table></div>"
},
"entry" : [
{
🔗 "reference" : "Observation/62e65dfb-d837-4556-8e75-2ca7a6fe6e40"
}
]
},
{
"title" : "Relevant diagnostic tests/laboratory data",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "30954-2",
"display" : "Relevant diagnostic tests/laboratory data note"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><thead><tr><th>Recent Lab Observations</th><th>15 Jul 2024</th><th>Reference Range</th><th>Unit</th></tr></thead><tbody><tr><td>Glucose [Mass/volume] in Blood</td><td><strong>65.9 L</strong></td><td>70 - 99</td><td>mg/dL</td></tr><tr><td>Urea nitrogen [Mass/volume] in Blood</td><td>9.2</td><td>7 - 20</td><td>mg/dL</td></tr><tr><td>Creatinine [Mass/volume] in Blood</td><td><strong>2.7 H</strong></td><td>0.6 - 1.3</td><td>mg/dL</td></tr><tr><td>Calcium [Mass/volume] in Blood</td><td>8.7</td><td>8.5 - 10.3</td><td>mg/dL</td></tr><tr><td>Sodium [Moles/volume] in Blood</td><td>136.4</td><td>135 - 145</td><td>mmol/L</td></tr><tr><td>Potassium [Moles/volume] in Blood</td><td>4.4</td><td>3.5 - 5.1</td><td>mmol/L</td></tr><tr><td>Chloride [Moles/volume] in Blood</td><td>101.2</td><td>98 - 108</td><td>mmol/L</td></tr><tr><td>Carbon dioxide, total [Moles/volume] in Blood</td><td>28.5</td><td>22 - 32</td><td>mmol/L</td></tr><tr><td>Protein [Mass/volume] in Serum or Plasma</td><td>6.9</td><td>6 - 8.3</td><td>g/dL</td></tr><tr><td>Albumin [Mass/volume] in Serum or Plasma</td><td>4.0</td><td>3.5 - 5</td><td>g/dL</td></tr><tr><td>Globulin [Mass/volume] in Serum by calculation</td><td>2.9</td><td>2 - 3.5</td><td>g/L</td></tr><tr><td>Bilirubin.total [Mass/volume] in Serum or Plasma</td><td>0.8</td><td>0.3 - 1.2</td><td>mg/dL</td></tr><tr><td>Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma</td><td>87.0</td><td>35 - 117</td><td>U/L</td></tr><tr><td>Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>45.0</td><td>7 - 46</td><td>U/L</td></tr><tr><td>Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td><strong>8.7 L</strong></td><td>10 - 40</td><td>U/L</td></tr><tr><td>Cholesterol [Mass/volume] in Serum or Plasma</td><td>193.2</td><td>125 - 200</td><td>mg/dL</td></tr><tr><td>Triglyceride [Mass/volume] in Serum or Plasma</td><td>149.3</td><td>0 - 199</td><td>mg/dL</td></tr><tr><td>Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay</td><td>129.5</td><td>0 - 159</td><td>mg/dL</td></tr><tr><td>Cholesterol in HDL [Mass/volume] in Serum or Plasma</td><td>62.7</td><td>50 - 100</td><td>mg/dL</td></tr></tbody></table></div>"
},
"entry" : [
{
🔗 "reference" : "Observation/faacb416-55b2-433a-82b9-9c5d84912df1"
}
]
},
{
"title" : "Device Use",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "46264-8",
"display" : "History of medical device use"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table class=\"hl7__ips\"><tr><th>Device</th><th>Date (since)</th></tr><tr><td>Home nebulizer (physical object)</td><td><span class=\"nb\">2021-06-21</span></td></tr><tr><td>Blood glucose meter (physical object)</td><td><span class=\"nb\">1991-02-18</span></td></tr></table></div>"
},
"entry" : [
{
🔗 "reference" : "DeviceUseStatement/9ee7b991-3240-42e3-9bcf-a1de0507754f"
}
]
}
]
}
IG © 2024+ HL7 Europe. Package hl7.fhir.eu.eps#1.0.0-ballot based on FHIR 4.0.1. Generated 2026-06-06
